GlassScriptPhysician profile
Beata K Grochowska
NPI 1194712018
$4,803.56
in general payments reported to CMS, 2019-2025
41 companies · $508 in 2025
The $508 reported for 2025 was more than what 91% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $952 · 2020: $939 · 2021: $1,630 · 2022: $400 · 2023: $180 · 2024: $194 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $882.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 4web, INC. | $811.81 | 2021 | |
| Medtronic, INC. | $701.66 | 2021-2025 | Inceptiv, Intellis Adaptivestim |
| Boston Scientific Corporation | $468.71 | 2019-2025 | General - Pain Management, Intracept Rf Probe |
| Stimwave Technologies Incorporated | $351.56 | 2020-2021 | |
| Medtronic USA, INC. | $247.81 | 2019-2020 | |
| Abbott Laboratories | $238.15 | 2019-2025 | Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $215.88 | 2019-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $183.27 | 2019-2020 | |
| Stryker Corporation | $172.01 | 2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $127.51 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $118.97 | 2019 | |
| Assertio Therapeutics, INC. | $117.86 | 2019 | |
| Forte Bio-Pharma LLC | $111.30 | 2020-2023 | Prolate, Nalocet |
| Nalu Medical, INC. | $94.74 | 2020 | |
| Daiichi Sankyo INC. | $74.68 | 2019 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beata Grochowska listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.